Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen 10% Cutaneous Spray in Acute Ankle Sprains
2006-000383-88Phase 3Completed
- Sponsor
- Angelini Pharma Österreich
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Ankle sprain comparing Ketoprofen 10% Cutaneous Spray with Placebo Cutaneous Spray (2 arms). Primary endpoint: Change in pain on active motion VAS between baseline and Day 3. Started Mar 2006; status: completed.
02
Drugs
ketoprofen
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2006-000383-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000383-88.